Agilent Q2 2021 revenue up 23%
Digitization

Agilent Q2 2021 revenue up 23%

The company has increased its outlook and now expects revenue in the range of $6.15 billion to $6.21 billion for fiscal year 2021

  • By ICN Bureau | May 27, 2021

Agilent Technologies has reported revenue of $1.525 billion for the second quarter ended April 30, 2021, an increase of 23% compared to the second quarter of 2020 and up 19% on a core basis. 

Second-quarter GAAP net income was $216 million or 70 cents per share. This compares with $101 million or 32 cents per share in the second quarter of fiscal year 2020. 

Non-GAAP net income was $299 million or 97 cents per share compared with $223 million or 71 cents per share during the second quarter a year ago. 

“The Agilent team delivered an exceptional quarter, exceeding our revenue and earnings expectations as our growth momentum continues,” said Mike McMullen, President and CEO, Agilent. 

“Our very strong growth is broad-based across all end-markets, geographies and business groups. These results reflect our relentless customer focus, innovative solutions, and excellent operational execution. Due to our strong-second quarter performance and expected continued momentum, we are raising our revenue and earnings outlook for the full year," commented McMullen. 

“We also welcomed the Resolution Bioscience team to Agilent in Q2, continuing our investment in high-growth markets as part of our ‘build and buy’ growth strategy,” added McMullen. 

Second-quarter revenue of $674 million from Agilent’s Life Sciences and Applied Markets Group (LSAG) increased 28% year-over-year and was up 25% on a core basis. 

Second-quarter revenue of $536 million from the Agilent CrossLab Group (ACG) increased 19% year-over-year and was up 15% on a core basis. 

Second-quarter revenue of $315 million from Agilent’s Diagnostics and Genomics Group (DGG) increased 20% year-over-year and was up 16% on a core basis. 

Agilent has increased its outlook and now expects revenue in the range of $6.15 billion to $6.21 billion for fiscal year 2021. Fiscal year 2021 non-GAAP earnings guidance has also increased to a range of $4.09 to $4.14 per share. 

Agilent expects third-quarter 2021 revenue in the range of $1.51 billion to $1.54 billion, with non-GAAP earnings expected to be in the range of 97 to 99 cents per share.

Register Now to Attend NextGen Chemicals & Petrochemicals Summit 2024, 11-12 July 2024, Mumbai

Other Related stories

Startups

Chemical

Petrochemical

Energy